| [1] |
WANG Xiaolei, MENG Zhaoyang.
Choroidal vascular characteristics is associated with retinal nerve fiber layer thickness in ocular hypertension and primary open-angle glaucoma
[J]. Basic & Clinical Medicine, 2026, 46(7): 990-997.
|
| [2] |
TIAN Jiao, TONG Jin.
Advances in the diagnosis and treatment of severe interstitial lung disease
[J]. Basic & Clinical Medicine, 2026, 46(6): 866-871.
|
| [3] |
CHEN Weixin.
Analysis of the immune characteristics of peripheral blood lymphocyte subsets in patients with early and advanced non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2026, 46(6): 823-829.
|
| [4] |
ZHU Min, TANG Miaomiao.
Advances in hydrogen sulfide therapy for acute lung injury
[J]. Basic & Clinical Medicine, 2026, 46(4): 592-596.
|
| [5] |
YUAN Ce, YE Cuicui, GUO Chang′an, LUO Laisheng, LIU Yuezhen.
Role of neutrophil extracellular traps in sepsis-related acute lung injury
[J]. Basic & Clinical Medicine, 2026, 46(4): 597-601.
|
| [6] |
LIU Pengpeng, SUN Zhao, QIU Wei, TANG Hui, ZHU Wenjia, WANG Wenhui, WANG Yingyi.
Impact of local radiotherapy on tyrosine kinase inhibitor treatment in non-small cell lung cancer with oligo-residual disease
[J]. Basic & Clinical Medicine, 2026, 46(4): 491-497.
|
| [7] |
ZHANG Zhen, YANG Lianren, HU Junkun, ZHANG Wei, LIANG Wei.
Value of serum D-dimer in evaluating chemotherapy effect and prognosis in patients with non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2026, 46(3): 417-420.
|
| [8] |
SONG Ning, LUO Junyi, JI Wei, LI Yanhong, LI Xiaomei, YANG Yining.
Knock-down MALAT1 reduces ox-LDL- induced-inflammation and cell damage of macrophages
[J]. Basic & Clinical Medicine, 2026, 46(3): 352-358.
|
| [9] |
NI Xing, LIU Fengchun, LU Lin, MAO Shaohua, BI Jirui, ZHANG Run.
PM2.5 in the air exacerbates lung injury in a mouse model of chronic obstructive pulmonary disease
[J]. Basic & Clinical Medicine, 2026, 46(1): 28-32.
|
| [10] |
ZHANG Yufeng, ZHANG Xinna, ZHOU Yanjiao.
PHLPP2 variation is associated with prognosis as well as ferroptosis in patients of advanced lung adenocarcinoma harboring EGFR+TP53 co-mutations
[J]. Basic & Clinical Medicine, 2026, 46(1): 103-108.
|
| [11] |
HUANG Qianqian, JIA Yufang, YU Huajun,CHEN Rongrong,CHEN Lili, WU Jun, ZHANG Haitao.
Stable knockout of ACSS3 in lung cancer cell line using CRISPR/Cas 9 technology
[J]. Basic & Clinical Medicine, 2025, 45(8): 1016-1021.
|
| [12] |
CHEN Lei,REN Weihao,WANG Lide.
Knockdown of translocase of inner mitochondrial membrane 8A enhances gefitinib sensitivity to lung cancer cell line PC-9
[J]. Basic & Clinical Medicine, 2025, 45(8): 1073-1077.
|
| [13] |
YANG Rui, DU Sifen, JIANG Lehui, FU Tian, REN Pengju, JIANG Chengyu, ZHANG Yanli.
Network pharmacology-based screening and validation of tea-derived small molecules against lung cancer
[J]. Basic & Clinical Medicine, 2025, 45(7): 939-946.
|
| [14] |
ZHU Qianmei, LI Qingyang, CHE Lu, HUANG Yuguang.
Disease-associated gut microbiota involvement and its mechanisms in the lung injury
[J]. Basic & Clinical Medicine, 2025, 45(5): 681-685.
|
| [15] |
JIA Huiwen, LIU Yun, XU Yun, YANG Qi, YANG Ke.
Serum miR-409-3p and miR-325-3p in primaryliver cancer are associated with the efficacy of interventional therapy
[J]. Basic & Clinical Medicine, 2025, 45(3): 341-345.
|